NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
April 29, 2025 — Skin, Bones, Hearts & Private Parts is hosting a CME conference in Hilton Head Island for healthcare professionals. Earn up to 26 CME credits. Expert speakers on Dermatology, Diabetes, Women's Health, and more.
April 29, 2025 — Federal whistleblower Dr. Kanwar Partap Singh Gill files a comprehensive 75-in-One Motion Suite in the Wellpath–H.I.G. bankruptcy case, challenging alleged procedural fraud and suppression, impacting healthcare integrity and creditor rights.
April 29, 2025 — Tevard Biosciences presents preclinical data on tRNA therapy for Duchenne Muscular Dystrophy at ASGCT Annual Meeting. Study shows rescue of dystrophin protein and restoration of motor function. Potential breakthrough in genetic disease treatment.
April 28, 2025 — BriaCell Therapeutics announces pricing of public offering to raise funds for advancing business objectives. Learn more about the underwritten public offering and its implications for the company.
April 28, 2025 — Calidi Biotherapeutics announces selection of IL15 superagonist for antitumor virotherapy platform, showcasing innovative cancer treatment approach with potential for enhanced immune response and tumor elimination.
April 28, 2025 — Kairos Pharma announces presentation of new data on KROS 101, a small molecule GITR ligand agonist, at ASCO Annual Meeting. CEO John Yu highlights the potential of KROS 101 in optimizing cancer treatment. ENV105, Kairos Pharma's lead candidate, targets CD105 to reverse drug resistance in cancer therapies.
April 28, 2025 — Senator Dave Cortese and Mothers’ Milk Bank California announce State Resolution 20 to designate May as California Human Milk Donation Month, emphasizing the critical role of donor milk in improving infant health outcomes. The initiative aims to increase awareness and recruit more donors to meet the growing demand for breast milk, ultimately saving lives.
April 28, 2025 — Nephros, Inc. introduces S100 In-Line filter for enhanced bacterial retention, providing versatile water safety solutions for medical, commercial, and industrial sectors. Learn more about the advanced filtration technology and broader application versatility.
April 28, 2025 — Creative Biolabs introduces innovative ADC technology enhancing cancer treatment efficacy and precision. Learn about bispecific ADCs targeting multiple receptors for improved therapeutic outcomes.
April 27, 2025 — Discover the latest premium health supplements from Me First Living, including mushroom complex, turmeric with black pepper, and biotin. Enhance your wellness journey naturally with products designed to support brain health, heart health, and beauty.
April 25, 2025 — Nutriband introduces AVERSA(TM) technology to enhance drug safety and accessibility. Learn about the company's innovative approach to pharmaceutical development and its potential impact on the industry. Stay informed about Nutriband's latest advancements in the field.
April 25, 2025 — D-Wave and Japan Tobacco partner on a quantum computing project to revolutionize drug discovery. Through the use of AI and quantum technology, they aim to enhance pharmaceutical design and accelerate treatments. Learn more about the impact of this innovative collaboration.
April 25, 2025 — Adageis introduces AI-powered financial technology platform for healthcare providers to transition to value-based care. Predicting revenue performance and optimizing financial efficiency, Adageis' solutions revolutionize healthcare operations.
April 25, 2025 — New study reveals link between bacteria and multiple sclerosis risk, offering potential treatment insights. Clene Inc. and BioMedWire play key roles in advancing research and communication in biotechnology and life sciences.
April 25, 2025 — Calidi Biotherapeutics announces an inducement grant to new CEO Dr. Eric Poma, highlighting the company's innovative approach to developing targeted antitumor virotherapies. The grant signifies confidence in leadership and potential for revolutionary cancer treatment.
April 25, 2025 — Soligenix (NASDAQ: SNGX), a biopharmaceutical company, reveals promising results for its lead candidate, HyBryte, in treating rare skin cancer. With a 75% response rate in clinical trials, HyBryte shows potential as a groundbreaking therapy for cutaneous T-cell lymphoma.
April 25, 2025 — Creative Biolabs leads in CIK cell therapy development for cancer treatment, offering one-stop solutions from concept to clinic. Learn how their innovative approach advances cancer immunotherapy research.
April 25, 2025 — Cancer Support Community SF Bay Area breaks ground on new cancer support center in Lafayette, CA as part of 'Rooted in Resilience' Capital Campaign. Key figures like Mayor of Lafayette and Congressman Mark DeSaulnier attend event to show support for comprehensive cancer care programs.
April 24, 2025 — GeoVax Labs responds to the detection of Clade I Mpox viral particles in North Carolina, emphasizing the need for expanded preparedness and vaccine availability. Learn how the company's GEO-MVA vaccine is advancing as a key U.S.-developed candidate for Mpox/smallpox.
April 24, 2025 — Utah Healthcare Innovation Network partners with local organizations to accelerate healthcare startups and drive innovation in the industry. Learn how this initiative is set to improve healthcare accessibility, affordability, and quality in Utah.